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Objective: Use of lungs from non–heart-beating donors would increase the pulmo-
nary donor pool. The aim of this study was to evaluate the effects of retrograde flush
in canine lung transplantation from non–heart-beating donors.
Methods: Left lung transplantation was performed in 12 weight-matched pairs of
dogs. Donors were killed without heparinization, left at room temperature for 2
hours, and then randomized into 2 groups. In group AF (n  6) lung retrieval was
performed after flushing the lung block with low potassium dextran glucose (50
mL/kg) solution through the pulmonary artery. In group AFRF (n  6) additional
retrograde flushing (low potassium dextran glucose, 25 mL/kg) was performed
through the left atrium before retrieval. Flushed solution was sampled at intervals to
measure hemoglobin concentrations. The lungs were preserved at 4°C for 2 hours,
and the left lung was implanted to the recipient being subjected to a total ischemic
time of 5 hours. After left lung transplantation, the right pulmonary artery and main
bronchus were ligated. Lung function, including arterial blood gas and pulmonary
hemodynamics, was measured for 3 hours. For lung function study, statistical
analyses were performed by using 1-way analysis of variance with repeated mea-
sures.
Results: Group AFRF had significantly better gas exchange and lower wet/dry
weight ratio of the transplanted lung than group AF. Changes of hemoglobin
concentration in the flushed solution indicated that additional retrograde flush could
remove residual microthrombi after antegrade flush.
Conclusions: This study supports the theory that additional retrograde flush im-
proves lung function after lung transplantation by removing residual pulmonary
microthrombi in the lungs of non–heart-beating donors.
The critical shortage of lungs for transplantation has resulted in longerwaiting times and annual increases in deaths on the lung transplantwaiting list. One of the strategies to increase the size of the pulmo-nary donor pool might be to use lungs harvested from non–heart-beating donors. A recent striking report on successful human lungtransplantation from non–heart beating donors by Steen and col-
leagues1 is gathering much attention.
In addition to the warm ischemic injury, intravascular pulmonary thrombi for-
mation appears to be one of the major causes of reperfusion injury in lung
transplantation from non–heart-beating donors. Retrograde flush through the pul-
monary vein has been used in experimental2-5 and clinical6,7 lung transplantation
and seems to offer better lung preservation with less edema and improved oxygen-
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ation. In this study we have evaluated the effects of retro-
grade flush in canine left single lung allotransplantation
from non–heart-beating donors.
Materials and Methods
Twelve weight-matched pairs of adult mongrel dogs (8.0-21.0 kg)
were used for left single lung allotransplantation. The donor dogs
were premedicated with an intramuscular injection of ketamine
hydrochloride (10 mg/kg) and atropine sulfate (0.02 mg/kg). Then
the donor dogs were anesthetized by means of intravenous injec-
tion of thiopental sodium (10 mg/kg) and intubated. The donors
were mechanically ventilated and killed by means of intravenous
injection of potassium chloride without heparinization. After the
mechanical ventilation was stopped, they were secured on the table
in the supine position and left at room temperature for 2 hours.
Then, through a median sternotomy, the main pulmonary artery
and the left atrial appendage were incised. Postmortem thrombus
in the pulmonary artery and left atrium was suctioned as much as
possible. Mechanical ventilation was re-established at a tidal vol-
ume of 20 mL/kg, a respiratory rate of 15 breaths/min, and a
positive end-expiratory pressure of 5 cm of H2O. Through the
main pulmonary artery, the lung block was antegradely perfused
with 50 mL/kg low potassium dextran glucose (LPDG) solution
stored at 4°C from a bag hung 50 cm above the chest. In group AF
(n  6) only antegrade flush was administered. In group AFRF
(n  6) an additional retrograde flush (25 mL/kg) was adminis-
tered through the left atrial appendage after ligation of the ascend-
ing aorta. Antegradely flushed solution was sampled from the left
atrium at designed intervals (at one third, two thirds, and the end
of the flush). Retrogradely flushed solution was sampled from the
pulmonary artery at the beginning and at the end of the additional
retrograde flush. Hemoglobin concentration was measured in each
sample. We removed biopsy specimens from the right lung for
histologic examination at the end of antegrade flush and at the end
of additional retrograde flush. The heart-lung block, semi-inflated
with 100% oxygen, was extracted, submerged in LPDG solution,
and stored at 4°C for 2 hours.
The recipient dogs were sedated in the same manner as the
donor dogs. General anesthesia was maintained with a 50:50
mixture of nitrous oxide and oxygen and 0.5% to 1.0% halothane.
TABLE 1. Characteristics of 2 experimental groups
Group
Donor weight
(kg)
Recipient
weight (kg)
Warm ischemic
time (min)
Cold ischemic
time (min)
Implantation
time (min)
Total ischemic
time (min)
AF (n  6) 12.8 3.9 13.7 4.3 120.8 1.9 112.7 10.6 67.7 10.4 300.3 2.9
AFRF (n  6) 12.9 2.5 13.2 2.8 122.2 3.1 112.7 6.3 68.5 5.6 302.0 3.4
All values are given as means  SEM.
TABLE 2. Assessment of lung and cardiac function of recipient
Function indicator
Before
transplantation
After transplantation
P value
(group
AF vs
group
AFRF)30 min 60 min 90 min 120 min 150 min 180 min
PaO2 (mm Hg)
Group AF 612.0 6.3 263.5 59.4 218.5 60.0 166.3 45.9 168.5 53.0 157.3 50.3 122.2 30.3
Group AFRF 593.0 24.5 459.3 50.2 441.8 50.7 433.2 52.8 397.3 52.3 369.5 50.6 394.5 47.3 .0057
PaCO2 (mm Hg)
Group AF 24.8 1.6 70.3 4.7 71.3 6.6 77.2 10.3 76.0 9.3 81.8 11.5 83.5 10.4
Group AFRF 24.8 0.8 56.7 2.4 60.3 2.6 59.3 1.5 57.7 1.4 58.7 0.8 61.3 1.8 .0702
Mean AoP (mm Hg)
Group AF 125.2 12.2 117.5 9.8 111.8 8.4 119.5 9.2 119.0 7.9 118.3 8.6 113.2 8.4
Group AFRF 132.2 6.8 122.8 3.7 118.8 6.8 126.8 14.3 128.2 13.8 126.5 7.0 124.5 11.6 .4676
Mean PAP (mm Hg)
Group AF 16.7 2.1 41.0 5.6 37.5 4.5 37.0 5.1 34.0 4.5 33.8 5.2 33.3 5.2
Group AFRF 17.2 1.4 35.0 4.3 33.5 4.6 33.7 3.8 31.7 3.9 29.8 3.7 28.7 3.3 .5363
Mean CVP (mm Hg)
Group AF 5.5 1.0 10.8 1.2 10.2 2.5 9.2 1.0 8.5 1.0 7.3 1.1 8.7 0.9
Group AFRF 5.8 0.8 10.7 2.3 10.2 1.0 9.2 2.3 8.2 1.6 7.8 1.4 8.2 1.4 .9896
Mean LAP (mm Hg)
Group AF 9.5 1.7 8.2 0.9 8.0 0.9 7.7 0.9 7.3 0.8 7.2 0.9 7.2 0.9
Group AFRF 9.8 1.2 8.3 0.6 6.8 0.5 6.8 0.6 6.8 0.7 6.3 0.3 6.8 0.5 .5998
CO (L/min)
Group AF 2.31 0.23 1.37 0.19 1.27 0.14 1.18 0.14 1.10 0.17 0.99 0.17 0.97 0.18
Group AFRF 2.66 0.24 1.75 0.31 1.74 0.28 1.63 0.31 1.57 0.33 1.56 0.29 1.39 0.23 .1749
All values are given as means  SEM. Data after transplantation were obtained with the right pulmonary artery and the right main bronchus ligated.
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A 5F Swan-Ganz catheter was placed in the main pulmonary artery
from the right femoral vein to measure pulmonary artery pressure
(PAP), central venous pressure (CVP), and cardiac output (CO). A
femoral artery line was inserted for measuring aortic pressure
(AoP) and for arterial blood gas analysis. After the baseline mea-
surement had been obtained, left pneumonectomy was performed
through the left fifth intercostal space. The right pulmonary artery
and the right main bronchus were encircled by 1-0 silk strings. A
5F catheter was inserted into the left atrial appendage to measure
left atrial pressure (LAP). On a back table, the left lung was
trimmed from the donor heart-lung block, and left lung implanta-
tion was performed.
After transplantation, both lungs were ventilated with a tidal
volume of 20 mL/kg and a positive end-expiratory pressure of 5
cm of H2O at a rate of 15 breaths/min and an inspired oxygen
concentration of 1.0. The right pulmonary artery and the right main
bronchus were ligated 15 minutes after reperfusion, forcing the
recipient to be dependent on the transplanted left lung for pulmo-
nary function, and then the tidal volume was reduced to 10 mL/kg.
The recipient dogs were observed for 3 hours, during which time
AoP, PAP, CVP, and LAP values were continuously recorded.
Measurement of CO and arterial blood gas analysis were per-
formed at specific intervals (30, 60, 90, 120, 150, and 180 minutes
after ligation of the right pulmonary artery and the right main
bronchus). The chest was not closed, but the lung was loosely
covered with normal saline solution–moistened sponges. After 3
hours of observation, the animals were killed with an overdose of
intravenous injection of potassium chloride and thiopental sodium.
The left upper and lower lobes were used to measure wet/dry
(W/D) weight ratio, which was determined by measuring the
weight difference in the specimen before and after being dried for
about 2 weeks in an oven kept at 90°C.
Animal Care
All dogs received human care in compliance with the “Principles
of Laboratory Animal Care” formulated by the National Society
for Medical Research and the “Guide for the Care and Use of
Laboratory Animals” prepared by the Institute of Laboratory An-
imal Resources, National Research Council, and published by the
National Academy Press, revised 1996.
Statistics
All values are given as means  SEM. One-way analysis of
variance with repeated measures was used to determine whether an
overall difference existed in lung function between the 2 groups
during the 3-hour assessment period.
Results
For the 2 groups, the donor weight, recipient weight, warm
ischemic time, cold ischemic time, implantation time, and
total ischemic time were similar (Table 1). All 12 animals
survived the operation and the 3-hour assessment period.
Pulmonary Function
The results of gas exchange and the hemodynamics of the
recipients during the 3-hour assessment period are shown in
Table 2.
PaO2 was significantly better in group AFRF than in
group AF (P  .0057). PaCO2 tended to be lower in group
AFRF than in group AF (P  .0702).
Mean AoP and LAP values were stable during the ex-
periment and were not significantly different between the 2
groups. Mean PAP and CVP values were significantly in-
creased by means of ligation of the right pulmonary artery
and bronchus (P  .001) in both groups but were not
significantly different between the 2 groups. CO was sig-
nificantly decreased (P  .001) by means of ligation of the
right pulmonary artery and bronchus but were not signifi-
cantly different between the 2 groups.
W/D Ratio
The W/D lung weight ratio in group AFRF was signifi-
cantly lower than that in group AF (7.52  0.33 vs 8.98 
0.41, P  .0195, unpaired Student t test; Figure 1).
Macroscopic and Microscopic Findings
After antegrade flushing, the donor lung surface looked
patchy macroscopically (Figure 2, A). After additional ret-
rograde pneumoplegia, the lung surface looked uniformly
perfused in group AFRF (Figure 2, B).
Histologic studies of samples of lung parenchyma ob-
tained after antegrade flushing demonstrated many residual
blood cells or blood clots (Figure 3, A). These blood cells or
blood clots were less observed after additional retrograde
flushing in group AFRF (Figure 3, B).
Hemoglobin Concentration of Flushed Solution
The change in the hemoglobin concentration of flushed
solution in group AFRF is shown in Figure 4. The hemo-
globin concentration of antegradely flushed solution col-
lected from the left atrium decreased gradually during an-
tegrade flush. The hemoglobin concentration of retrogradely
flushed solution collected from the pulmonary artery at the
Figure 1. W/D lung weight ratio of transplanted lung after a 3-hour
assessment period. The ratio was significantly lower in group
AFRF (7.52  0.33) than in group AF (8.98  0.41; P  .0195).
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beginning of retrograde flush was significantly greater than
that at the end of antegrade flush (267.0  93.6 vs 110.5 
20.7 mg/dL, paired Student t test; P  .0422; Figure 4).
Discussion
Because the oxygen supply is interrupted during the pres-
ervation period, solid organs lose viability fairly rapidly,
even during cold ischemia, as a result of anaerobic metab-
olism. The lung is the only organ that can be preserved with
a ready supply of oxygen through the airway.8 Lung trans-
plantation from non–heart-beating donors is based on the
notion that pulmonary cellular elements might remain via-
ble by using the oxygen in the alveoli for a certain period at
warm temperature, even after cessation of circulation. Sev-
eral strategies have been developed in an attempt to reduce
warm ischemia-reperfusion injury (eg, oxygen radical scav-
engers,9 topical cooling,10,11 ventilating lungs,12 and inhaled
nitric oxide13,14).
In addition to warm ischemic injury, microthrombi for-
mation appears to be one of the major detrimental factors in
lung transplantation from non–heart-beating donors, in
which lungs are essentially preserved with warm whole
blood. Microthrombi formation would result in an increase
of intrapulmonary shunt, leading to hypoxia. Associated
high precapillary pressure would further enhance poor gas
exchange caused by lung edema. Eagan and coworkers15
demonstrated that a safe period of ischemia for the lung at
normothermia is less than 2 hours without heparinization.
Ulicny and colleagues12 demonstrated that the acceptable
warm ischemic time could be extended to 4 hours when the
lungs were fully heparinized before cardiac arrest and kept
ventilated after death. For the concept of lung transplanta-
tion from non–heart-beating donors to be practical, it would
be difficult to administer any pretreatment to the donor
before death. In fact, heparinizing the donor for the purpose
of organ donation is strictly restricted in Japan.
Then how do we deal with microthrombi in the lungs of
non–heart-beating donors without pretreatment? There are
several potential methods. Steen and associates1 adminis-
tered heparin into a central venous catheter 10 minutes after
declaration of death followed by 20 chest compressions in
their successful human lung transplantation from a non–
heart-beating donor. Microthrombi formation might be pre-
vented with this method; however, it would be essential to
administer heparin shortly after cardiac arrest. Our group
has demonstrated that fibrinolytic drugs, such as urokinase16
or recombinant tissue-type plasminogen activator,17 im-
prove lung function when they are administered into the
lungs of non–heart-beating donors at 2 hours after cardiac
arrest. We hypothesized that mechanical washout of pre-
existing pulmonary microthrombi by means of retrograde
flush would improve lung function in lung transplantation
from non–heart-beating donors.
Retrograde flush through the pulmonary vein or the left
atrium has been used in experimental2-5 and clinical6,7 lung
transplantation and seems to offer better lung preservation
with less edema and improved oxygenation. Chen and co-
workers2 simply compared antegrade flush and retrograde
flush in canine left lung cold preservation for 6 hours and
found that retrograde flush was superior in terms of gas
Figure 2. Macroscopic findings of donor lung in group AFRF. A, End of antegrade flush. The lung surface looked
patchy, indicating inhomogeneous perfusion. B, End of additional retrograde flush. The lung surface looked
uniformly perfused, indicating that retrograde pneumoplegia could reach vascular segments that were not flushed
by means of the forward route.
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exchange and airway pressure. Baretti and colleagues3
showed that retrograde flush of pneumoplegic solution im-
proved flow to distal trachea and bronchi without prostacy-
clin compared with antegrade flush. This study suggested
that retrograde pneumoplegia has the advantage of flushing
the bronchial circulation through the bronchopulmonary
anastomoses, enhancing airway protection. Stru¨ber and as-
sociates4 reported that the disturbance of surfactant function
was less pronounced in the retrograde flush group than in
the antegrade flush group. A clinical advantage of retro-
grade flush was demonstrated by Venuta and coworkers7 in
their human lung transplant program. They performed an-
tegrade flushing at the time of retrieval, and additional
retrograde flushing through the pulmonary veins was per-
formed at the back table before implantation.
In the present study it was clearly shown that additional
retrograde flush improved gas exchange and resulted in less
edema, as demonstrated by W/D lung weight ratio. The
mechanical washout of pre-existing pulmonary micro-
thrombi by means of retrograde flush was observed macro-
scopically (Figure 2, A and B) and microscopically (Figure
3, A and B). This phenomenon was further confirmed by the
changes of hemoglobin concentration in the flushed solution
(Figure 4). These results strongly suggested that there were
some residual microthrombi wedged in the precapillary area
after antegrade flush, and they were removed by the addi-
tional retrograde flush. Luh and coworkers5 also reported
Figure 3. Histologic studies of samples of donor lung parenchyma in group AFRF. (Hematoxylin and eosin stain;
original magnification 100.) A, End of antegrade flush. Many residual blood cells or blood clots were observed
in the capillary. B, End of additional retrograde flush. These blood cells or blood clots were less observed,
indicating that retrograde pneumoplegia could reach a vascular segment that was not flushed by means of the
forward route.
Figure 4. Change in hemoglobin concentration of flushed solution
in group AFRF. The hemoglobin concentration was significantly
higher at the beginning of retrograde flush (267.0  41.2 mg/dL)
than at the end of antegrade flush (110.5  20.7 mg/dL; P  .0422).
AF1, One third of antegrade flush; AF2, two thirds of antegrade
flush; AF3, end of antegrade flush; RF1, beginning of retrograde
flush; RF2, end of retrograde flush.
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that the retrograde flush might be beneficial to the protection
of the non–heart-beating donor lung grafts at an early
reperfusion period in their experimental study. However, in
the study by Luh and coworkers, the lungs were kept
ventilated after cardiac arrest. For the concept of lung trans-
plantation from non–heart-beating donors to be practical,
we did not administer any pretreatment to the donor before
death and for 2 hours after death. The excellent lung func-
tion demonstrated in group AFRF in this study by using a
cadaver lung left at room temperature for 2 hours without
heparinization and preserved with LPDG solution for 2
hours (total ischemic time of 5 hours, including implanta-
tion time) is very encouraging.
We acknowledge the expert technical assistance of Tetsuo
Kawakami and the statistical advice of Richard B. Schuessler,
PhD.
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